← back to ideas

NeoAntigen Treatment Navigator

8.2
healthcare profitable added: Friday April 2026 23:01

A software platform to help oncologists and researchers navigate the rapidly evolving landscape of individualized neoantigen cancer treatments, leveraging AI to analyze genomic data and predict treatment efficacy, based on Moderna's expansions.

220h
mvp estimate
8.2
viability grade
0
views

technology stack

Python PostgreSQL Difficult Data

inspired by

Moderna faces dilemma in naming next-gen mRNA treatments